"Beckman Coulter Diagnostics' commitment to delivering high ... Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered ...

Like Bio-Hermes-001, the Bio-Hermes-002 study is setting a standard for improving participation from people who are traditionally underrepresented in Alzheimer's clinical research, with an ...

BREA, Calif., Jan. 28, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration (FDA) has granted ...

The new QbD1200 TOC analyzer from Beckman Coulter is designed to make testing easier, reproducible and accurate. The new TOC analyzer promises highest performance while dramatically reducing cost ...

Washington D.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes ...

At Beckman Coulter, innovation doesn't stop with our liquid handling systems. Our Biomek Tips and Labware have been specifically tailored to meet the growing laboratory needs in genomics ...

BREA, Calif., Jan. 15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only (RUO) blood-based biomarker ...

BREA, Calif., Jan. 15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only (RUO) blood-based biomarker ...